MAIA Biotechnology Highlights Ongoing Momentum of Ateganosine Clinical Program at SITC 2025
Company confirms 12 patients enrolled in Phase 2 THIO-101 to date as…
PMV Pharmaceuticals Announces Updated Rezatapopt Monotherapy Interim Data From Ongoing PYNNACLE Phase 2 Trial Across Multiple Solid Tumors With a TP53 Y220C Mutation
October 24, 2025 11:39 ET | Source: PMV Pharmaceuticals, Inc. Data presented…
Galapagos Announces Intention to Wind Down Cell Therapy Business as Part of the Companys Ongoing Transformation
Intention follows comprehensive strategic review process and would represent the optimal capital…
PMI Calls for Ongoing G2G Dialogues with Source and Transit Countries to Combat Illicit Tobacco Trade
- India faces an annual loss of approximately $1.65 billion, with 25%…
Aviva and FNZ unveil latest innovations to enhance adviser experience
Aviva platform continues development of innovative technology to support advisers.The latest innovation,…
The Billion-Dollar Heist and What It Means for Crypto Security: Bybit’s Security Overhaul After Hack
DUBAI, UAE, June 4, 2025 /PRNewswire/ -- Bybit, the world's second-largest cryptocurrency exchange…
ERA Congress: Long-term data show sustained efficacy and safety of zigakibart in patients with IgA nephropathy
VIENNA, June 5, 2025 /PRNewswire/ -- New 100-week data from the ongoing…
